top of page
Executive Spotlights

Seismic Therapeutic Closes $121M Series B Financing

Cambridge, MA, December 4, 2023 (Business Wire) -- Seismic Therapeutic, Inc., the machine learning immunology company, has announced the completion of a $121 million Series B financing. The Series B was led by new investor Bessemer Venture Partners with participation from other new investors, including Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels, and GC&H.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Kommentare


Life Science Headlines
bottom of page